← Leaderboards
Elizabeth S Kaufman
Case Western Reserve University
$156,444
Attributed
$156,444
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.1K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$156,444 · 7
By mechanism
M01$156,444 · 7
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Igor R Efimov$20,527,065
- Arthur M Brown$3,774,415
- Albert L Waldo$2,672,360
- Zahra Toossi$8,027,247
- Tina Louise Vrabec$6,554,221
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationArrhythmiaAtrial FibrillationNoninvasive DiagnosisPatient Monitoring DeviceCase HistoryLong Qt SyndromeGenetic ScreeningComputer Assisted DiagnosisCongestive Heart FailureDisease /Disorder Proneness /RiskAce InhibitorsAmiodaroneImplantable DefibrillatorsCardiovascular Disorder DiagnosisFamily GeneticsElectrocardiographyLongitudinal Human StudyMedical ComplicationGenetic SusceptibilityHeart ArrestSudden Cardiac Death
Grant awards (20)
NONINVASIVE & GENETIC TECHNIQUES TO REFINE THE DIAGNOSIS OF THE LONG QT SYNDROME$43,982
M01 · FY2006 · RR · contact PI
NONINVASIVE &GENETIC TECHNIQUES TO REFINE THE DIAGNOSIS OF THE LONG QT SYNDROME$28,574
M01 · FY2005 · RR
LONG QT SYNDROME: USE OF THE POTASSIUM CHANNEL BLOCKER ERYTHROMYCIN$18,521
M01 · FY2005 · RR
Noninvasive &genetic techniques to refine the diagnosis of the long QT segment$35,254
M01 · FY2004 · RR
Long QT Syndrome: Use of the potassium channel blocker erythromycin$13,220
M01 · FY2004 · RR
Significance of T-wave alternans in patients with congestive heart failure$8,814
M01 · FY2004 · RR
Sudden cardiac death in heart failure trial (SCD-Heft)$7,712
M01 · FY2004 · RR
QT interval prolongation in postpartum women$367
M01 · FY2004 · RR
Atrial fibrillation follow up of rhythm management$0
M01 · FY2002 · RR
Noninvasive &genetic diagnosis of long QT segment$0
M01 · FY2002 · RR
Symptomatic arrhythmia in perimenopausal women &hormone$0
M01 · FY2002 · RR
Sudden cardiac death in heart failure trial of prophylactic amiodarone or defibri$0
M01 · FY2002 · RR
Noninvasive &genetic diagnosis of long QT segment$0
M01 · FY2001 · RR
Sudden cardiac death in heart failure trial of prophylactic amiodarone or defibri$0
M01 · FY2001 · RR
Atrial fibrillation follow up of rhythm management$0
M01 · FY2001 · RR
Symptomatic arrhythmia in perimenopausal women &hormone$0
M01 · FY2001 · RR
Symptomatic arrhythmia in perimenopausal women &hormone$0
M01 · FY2000 · RR
Sudden cardiac death in heart failure trial of prophylactic amiodarone or defibri$0
M01 · FY2000 · RR
Atrial fibrillation follow up of rhythm management$0
M01 · FY2000 · RR
Noninvasive &genetic diagnosis of long QT segment$0
M01 · FY2000 · RR